The growth of the acute ischemic stroke market is expected to be driven primarily by increased awareness of symptoms, advances in acute stroke care, and a robust pipeline of potential candidates such ...

Mordor Intelligence has published a new report on critical ischemia treatment market offering a comprehensive analysis of ...

Company to Highlight Imaging Biomarkers for Cytoprotection and Post Hoc Analysis from Phase 2 RESCUE Clinical Trial; RNS60 ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

Some patients with a common type of stroke benefit from a clot-busting drug given between 4.5 and 24 hours after symptoms emerged, according to a new study.

Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the most effective ...

Treatment is determined by the type of stroke suffered (i.e., ischemic or hemorrhagic) rather than the anatomic location. Symptoms referable to the anterior circulation — specifically, anterior and ...

Ischemic colitis and mesenteric ischemia are both types of bowel ischemia. Ischemic colitis refers to reduced blood flow to the large intestine, while mesenteric ischemia happens due to reduced blood ...

Mesenteric ischemia, or small bowel ischemia, involves a blockage of blood flow to the small intestine. Symptoms include pain and bloating. It often results from blood clots or atherosclerosis.

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...